October 25, 2021
NOT-CA-21-101 - Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules
PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to correct the Key Dates, Related Announcements, and Application and Submission Information in NOT-CA-21-101, "Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules".
The following subsections of NOT-CA-21-101 have been modified:
Currently Reads:
Key Dates
Release Date: August 16, 2021
First Available Due Date: January 26, 2022
Expiration Date: January 08, 2024
Related Announcements
PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PAR-20-292 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-21-038 - Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
PAR-19-133 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
PAR-19-134 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Application and Submission Information
This Notice applies to due dates on or after January 26, 2022, and subsequent receipt dates through January 08, 2024.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this NOSI:
|
Activity Code |
FOA Title |
First Available Due Date |
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
February 5, 2022 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
February 22, 2022 |
|
|
Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
January 26, 2022 |
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) |
February 25, 2022 |
|
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 - Clinical Trial Not Allowed) |
February 25, 2022 |
Modified to Read (changes shown in bold italics):
Key Dates
Release Date: August 16, 2021
First Available Due Date: January 8, 2022
Expiration Date: May 8, 2024
Related Announcements
PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
PAR-20-292 -NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
PAR-21-038 - Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
PAR-21-155 - Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
PAR-19-134 - Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 - Clinical Trial Not Allowed)
Application and Submission Information
This Notice applies to due dates on or after January 8, 2022, and subsequent receipt dates through May 8, 2024.
Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcements through the expiration date of this NOSI:
|
Activity Code |
FOA Title |
First Available Due Date |
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
February 5, 2022 |
|
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
February 22, 2022 |
|
|
Stephen I. Katz Early-Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
January 26, 2022 |
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed) |
February 25, 2022 |
|
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 - Clinical Trial Not Allowed) |
January 8, 2022 |
All other aspects of NOT-CA-21-101 remain unchanged.
Scientific Research Contact(s)
Sharad K. Verma, PhD
National Cancer Institute (NCI)
Telephone: 202-657-3694
Email: sharad.verma@nih.gov
Financial/Grants Management Contact(s)
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: wolfreyc@mail.nih.gov
and Human Services (HHS)
